Notable
XYA02 · Advanced Solid Tumors
Recruitment opened
Also in this update: Primary completion pushed from Jul 15, 2029 to Sep 15, 2029; Study completion pushed from Jul 15, 2030 to Sep 15, 2030
XYone Therapeutics, IncPhase 1/2 NCT07670312 Registry history of NCT07670312 on ClinicalTrials.gov (opens the registry)